Compare SRRK & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | ATGE |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.8B |
| IPO Year | 2018 | 1991 |
| Metric | SRRK | ATGE |
|---|---|---|
| Price | $47.62 | $104.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $51.20 | ★ $145.67 |
| AVG Volume (30 Days) | ★ 1.0M | 488.7K |
| Earning Date | 02-26-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.41 |
| EPS | N/A | ★ 6.76 |
| Revenue | N/A | ★ $1,888,834,000.00 |
| Revenue This Year | N/A | $9.83 |
| Revenue Next Year | $20,029.43 | $6.11 |
| P/E Ratio | ★ N/A | $15.27 |
| Revenue Growth | N/A | ★ 11.92 |
| 52 Week Low | $22.71 | $86.26 |
| 52 Week High | $49.82 | $156.26 |
| Indicator | SRRK | ATGE |
|---|---|---|
| Relative Strength Index (RSI) | 53.53 | 44.36 |
| Support Level | $44.10 | $97.24 |
| Resistance Level | $49.82 | $124.60 |
| Average True Range (ATR) | 2.35 | 5.44 |
| MACD | -0.01 | -1.96 |
| Stochastic Oscillator | 45.47 | 29.86 |
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.